abstract |
The present specification provides isolated, engineered, non-naturally occurring CB1 binding proteins, including anti-CB1 antibodies or antigen-binding fragments thereof. The CB1 binding proteins have use in the treatment and diagnosis of CB1 mediated conditions, diseases and disorders. |